Structural defects in mitochondria have been reported in various pathogenic LRRK2 models, including LRRK2 G2019S mouse models [129,130,131], LRRK2 PD patient-derived cells [91,132,133,134], and other cellular systems [135,136,137]. The gene discussed is LRRK2; the disease is Parkinson disease.